|
| Press Releases |
|
 |
|
| Monday, November 27, 2017 |
|
|
南旋公布二零一八年度中期业绩 |
| 中国领先的针织品制造商之一南旋控股有限公司（「南旋」或「集团」，股份代号:1982)今天公布其截至二零一七年九月三十日止六个月（「二零一八财年上半年」或「回顾期」）的中期业绩。 more info >> |
|
|
南旋公布二零一八年度中期業績 |
中國領先的針織品製造商之一南旋控股有限公司 （「南旋」或「集團」，股份代號:1982)今天公布其截至二零一七年九月三十日止六個月（「二零一八財年上半年」或「回顧期」）的中期業績。
more info >> |
|
|
Nameson Announces 2018 Interim Results |
| Nameson Holdings Limited ("Nameson" or the "Group", stock code: 1982), one of the leading knitwear manufacturers in the PRC, today announced its interim results for the six months ended 30 September 2017 ("FY2018 1H" or the "Review Period"). more info >> |
|
| Monday, November 28, 2016 |
|
|
南旋公布二零一七年中期业绩 |
中国领先的针织品制造商之一南旋控股有限公司(「南旋」或「集团」，股份代号:1982)今天公布其截至二零一六年九月三十日止六个月(「2017财政年度上半年」或「回顾期」)的中期业绩。
more info >> |
|
|
南旋公布二零一七年中期業績 |
中國領先的針織品製造商之一南旋控股有限公司 (「南旋」或「集團」，股份代號:1982)今天公布其截至二零一六年九月三十日止六個月 (「2017財政年度上半年」或「回顧期」)的中期業績。
more info >> |
|
|
Nameson Announces 2017 Interim Results |
Nameson Holdings Limited ("Nameson" or the "Group", stock code: 1982), one of the leading knitwear manufacturers in the PRC, today announced its interim results for the six months ended 30 September 2016 ("FY2017 1H" or the "Review Period").
more info >> |
|
| Tuesday, June 28, 2016 |
|
|
南旋公布二零一六年全年业绩 |
中国领先的针织品制造商之一南旋控股有限公司(「南旋」或「集团」，股份代号:1982)公布其于二零一六年四月十二日在香港联合交易所有限公司主板上市后，截至二零一六年三月三十一日止年度(「二零一六年财年」或「回顾年内」) 的全年业绩。
more info >> |
|
|
南旋公布二零一六年全年業績 |
中國領先的針織品製造商之一南旋控股有限公司 (「南旋」或「集團」，股份代號:1982)公布其於二零一六年四月十二日在香港聯合交易所有限公司主板上市後，截至二零一六年三月三十一日止年度 (「二零一六年財年」或「回顧年內」) 的全年業績。
more info >> |
|
|
Nameson Announces 2016 Annual Results |
| Nameson Holdings Limited ("Nameson" or the "Group", stock code: 1982), one of the leading knitwear manufacturers in the PRC, announced its annual results for the year ended 31 March 2016 ("FY2016" or the "Review Year"), more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Mr Liu Xiaojun, on behalf of Fufeng Group, has fully completed the acquisition of Viva World Trade, Inc.
Feb 7, 2026 05:45 HKT/SGT
|
|
|
GIC Invests US$100M in Ascletis Pharma (1672. HK): Anchoring Long-Term Capital in China's Core Innovative Drug Assets
Feb 6, 2026 17:45 HKT/SGT
|
|
|
GIC Private Limited initiated a stake in Ascletis Pharma (01672) by 64,128,000 shares at a price of HKD 12.18 per share
Feb 6, 2026 17:01 HKT/SGT
|
|
|
歌禮製藥-B（01672）獲新加坡政府投資公司首次入股 涉資約1億美元
Feb 6, 2026 16:56 HKT/SGT
|
|
|
歌礼制药-B（01672）获新加坡政府投资公司首次入股 涉资约1亿美元
Feb 6, 2026 16:50 HKT/SGT
|
|
|
COSMOPlat Introduces Full-Stack AI to Hong Kong for Trillion-Dollar Industrial Digitalization
Feb 6, 2026 16:34 HKT/SGT
|
|
|
トヨタ、役員人事を発表
Feb 6, 2026 16:00: JST
|
|
|
牧原股份港股上市：全球生豬养殖龍頭 價值成長兼具
Feb 6, 2026 15:08 HKT/SGT
|
|
|
牧原股份港股上市：全球生猪养殖龙头 价值成长兼具
Feb 6, 2026 15:01 HKT/SGT
|
|
|
優異供應鏈賦能與國際化佈局雙輪驅動 綠茶開啟高質量成長新篇章
Feb 6, 2026 14:47 HKT/SGT
|
|
|
优异供应链赋能与国际化布局双轮驱动 绿茶开启高质量成长新篇章
Feb 6, 2026 14:33 HKT/SGT
|
|
|
Everest Medicines Announces China NMPA Approval of VELSIPITY(R) for Adults with Moderately to Severely Active Ulcerative Colitis
Feb 6, 2026 14:17 HKT/SGT
|
|
|
雲頂新耀維適平(R)獲中國國家藥品監督管理局批准上市 為中重度潰瘍性結腸炎治療提供新選擇
Feb 6, 2026 14:11 HKT/SGT
|
|
|
云顶新耀维适平(R)获中国国家药品监督管理局批准上市 为中重度溃疡性结肠炎治疗提供新选择
Feb 6, 2026 14:03 HKT/SGT
|
|
|
Spritzer Celebrates Continued Excellence with Dual Recognition at Putra Brand Awards 2025 and Superior Taste Award 2025
Feb 6, 2026 13:13 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
